The first participant was enrolled on March 4, 2024, and the last participant completed enrollment on July 15, 2024
Optimizes, not treats
Growth HormoneRelated and Recovery Peptides These peptides stimulate or modulate growth hormone (GH) release, which in turn influences IGF1 levels, tissue repair, body composition, and recovery
In addition, there was evidence of a significant reduction in average loop diuretic dose, a lower likelihood of diuretic treatment escalation, and a greater likelihood of diuretic treatment de-escalation with semaglutide versus placeboparameters that indicate disease-modifying effects of semaglutide, and are associated with better long-term clinical outcomes in this patient population. Photo 288328289 Fernanda Carrasco | Dreamstime.com
No increase in QTc was observed with either 25 mg or 200 mg empagliflozin
The PBM system is under more pressure than at any point in its 50-year history